脏的宁-血管酶系统:在RAS级联中丢失
Steven D Crowley1, L Gabriel Navar2, Minolfa C Prieto2
1Division of Nephrology, Department of Medicine, Duke University and Durham VA Medical Centers, Durham, NC (S.D.C.).
Hypertension (Dallas, Tex. : 1979)
|March 20, 2024
概括
脏中的氨酸- ангиотензин系统对于功能和疾病至关重要. 了解其复杂性,包括像前林因受体这样的新组件,有助于开发更好的脏和心血管疾病治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管生理学心血管生理学
- 内分泌学 在内分泌学.
背景情况:
- 一个多世纪以来,人们一直在研究氨酸-血管氨系统 (RAS).
- 它在脏生理学和心血管和脏疾病的发展中的关键作用已经得到了很好的证实.
- 目前针对RAS的治疗方法是管理高血压,心力衰竭和糖尿病病的基础.
研究的目的:
- 探索内宁-血管素系统的复杂调节.
- 突出新发现的非经典RAS组件的重要性,如前列宁受体 (PRR) 和血管素转化酶2 (ACE2).
- 强调性RAS对更广泛的心血管系统的影响.
主要方法:
- 审查现有的关于氨酸 - 血管酶系统研究的文献.
- 对RAS调节和新组件的新兴研究的分析.
- 综合与脏生理学和疾病发病学相关的发现.
主要成果:
- 目前正在进行的研究继续揭示内RAS调节的新复杂性.
- 像PRR和ACE2这样的非经典成分对脏有显著的影响,具有系统性心血管影响.
- 对脏RAS的全面了解对于推进治疗策略至关重要.
结论:
- 脏的氨酸 - 血管增生酶系统仍然是一个充满活力的研究领域,对许多疾病有影响.
- 新兴的组件和监管机制需要有效治疗的最新理解.
- 未来心血管和脏疾病的治疗进展将从对脏RAS的详细知识中受益.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
621
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
621
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
631
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
631
01:33Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
726
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
726
01:13Introduction to Urinary System
2.5K
The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
2.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428